Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Notal Vision Ltd.
The HMP device is intended to aid patients in identifying their visual abnormalities and in addition to their own symptoms or Amsler grid use and aid in their prompt referral to eye care professional examination so clinical diagnosis can be made. As such the goal of the clinical plan is to demonstrate that patients who have CNV do demonstrate visual field abnormalities when tested with the HMP
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Capable and willing to sign a consent form and participate in the study
subjects with AMD related lesions: New onset (up to 60 days) non-treated CNV
Age \>50 years
VA with habitual correction \>20/200 in study eye
Familiar with computer usage
You may not be if
Evidence of macular disease other than AMD or glaucoma in the study eye
Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP, or FA
Any non-macular related ocular surgery performed within 3 months prior to study entry in the targeted eye
Inability to tolerate intravenous FA
Participation in another study with the exclusion of AREDS study
